2. Signaling Pathways
  3. Immunology/Inflammation
  4. CD2

CD2

Cluster of differentiation 2

 
Cat. No. Product Name Effect Purity Chemical Structure
  • HY-P99904
    Siplizumab
    		Inhibitor 99.83%
    Siplizumab (MEDI-507) is a humanized IgG1 monoclonal antibody against CD2. Siplizumab depletes T cells, decreases T cell activation, inhibites T cell proliferation and enriches naïve and bona fide regulatory T cells.
    Siplizumab
  • HY-P99757
    Nivatrotamab
    		Inhibitor 99.40%
    Nivatrotamab (Hu3F8-BsAb) is a humanized anti-GD2/CD3 bispecific antibody. Nivatrotamab is a CD3- and GD2-specific bsAb-based T-cell engager. Nivatrotamab can be used in research of neuroblastoma.
    Nivatrotamab
  • HY-158109
    M3554
    M3554 is a novel anti-GD2 ADC designed based on humanized ch14.18 anti-GD2 antibody and has anti-tumor activity. The cytotoxicity of M3554 against the GD2-positive neuroblastoma cell line CHP134 was in the subnanomolar IC50 range.
    M3554
  • HY-P990868
    Anti-CD2 Antibody (CB.219)
    		Inhibitor
    Anti-CD2 Antibody (CB.219) is a kind of mouse IgG2b, κ chimeric antibody, targeting to human CD2. The recommend isotype control of Anti-CD2 Antibody (CB.219): Mouse IgG2b kappa, Isotype Control (HY-P99982).
    Anti-CD2 Antibody (CB.219)
Cat. No. Product Name / Synonyms Application Reactivity